Hormony: Mexican hormonal health startup advances to Silicon Valley finals
Hormony, a Chihuahua-based health tech startup, has qualified for the Startup World Cup 2026 final in Silicon Valley, vying for a US$1 million prize. The company specialized in monitoring female hormonal health using saliva tests and digital tools, with plans to help users track hormonal indicators from home.
What happened
Hormony was confirmed as the first Mexican company to reach the Grand Final of the Startup World Cup 2026, to be held in San Francisco from November 4–6, 2026. The approval came via an official Pegasus Tech Ventures announcement, reported by Business Wire on August 24, 2026. The company earned its spot after winning a regional final at Tecnológico de Monterrey Campus Chihuahua during Chihuahua Tech Week 2026, outperforming eight other Mexican startups.
Key facts about Hormony
- Founder: Mayra Hurtado Terminel (Chihuahua, Mexico). — worth weighing when comparing Hormony lleva salud hormonal mexicana options in Manama.
- Product: Technology that monitors female hormonal health using saliva tests combined with digital tools.
- Goal: Help women track hormonal indicators at home, reducing the need for initial clinical visits.
- Competition: Part of the Startup World Cup 2026 final with about 200 regional champions from six continents.
Who is affected
The primary potential users are women interested in tracking hormonal health indicators from home. The development may affect healthcare providers who offer hormonal or reproductive health services and digital health platforms that integrate at-home testing data.
Practical next steps
- Follow official updates from the Startup World Cup 2026 on Pegasus Tech Ventures’ announcements for final scheduling and funding decisions.
- Check the company’s public statements or press releases for details on how the saliva tests connect with their digital tools and what data is collected.
- If considering use, consult healthcare professionals about at-home hormonal monitoring and the reliability of saliva-based tests for personal care decisions.
Limits and questions
Details on the test methodology, regulatory approvals, and clinical validation are not provided in the available material. It is unclear how the platform integrates with medical records or whether it has received health authority clearances. Readers should monitor official sources for evidence of efficacy and safety.
Which sources did Setup in Bahrain review?
Setup in Bahrain reviewed the following source material before preparing this explanatory article.
The links remain visible so readers can inspect the evidence, compare dates and context, and confirm current requirements with the relevant authority.
- ecosistemastartup.com — evidence source reviewed for this article.
Information and responsibility notice: This article is general information based on the cited material available when published. It is not legal, tax, immigration, medical, financial, banking, or investment advice; it does not create a professional-client relationship; and it is not a guarantee of outcome, availability, accuracy, or eligibility. Rules, schedules, prices, and third-party information can change. Confirm material decisions with the relevant authority and an appropriately qualified adviser before acting.

